Identification of Novel Piperazinylquinoxaline Derivatives as Potent Phosphoinositide 3-Kinase (PI3K) Inhibitors

• Peng Wu,

  Affiliation Zhejiang University - École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China

  ⨯
• Yi Su,

  Affiliation Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China

  ⨯
• Xianghong Guan,

  Affiliation Zhejiang University - École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China

  ⨯
• Xiaowen Liu,

  Affiliation Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China

  ⨯
• Jiankang Zhang,

  Affiliation Zhejiang University - École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China

  ⨯
• Xiaowu Dong,

  Affiliation Zhejiang University - École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China

  ⨯
• Wenhai Huang,

  Affiliation Zhejiang University - École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China

  ⨯
• Yongzhou Hu

  * E-mail: huyz@zju.edu.cn

  Affiliation Zhejiang University - École Normale Supérieure Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China

  ⨯